EUVIMEDEUVIMED entdecken
Crossref

Inhaled exogenous thymosin beta 4 suppresses bleomycin-induced pulmonary fibrosis in mice via TGF-β1 signalling pathway

Rui Yu, Shimeng Li iD, Li Chen iD, Enbo Hu, Dan Chai, Zhichao Liu, Qianyi Zhang, Yunyun Mao, Yanfang Zhai, Kai Li, Yanhong Liu, Xiaohe Li und 3 weitere

Journal of Pharmacy and Pharmacology · 2025

DOI: 10.1093/jpp/rgae143 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pharmacy and Pharmacology, 2025. Verfasst von Rui Yu und 14 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biotechnology, Academy of Military Medical Sciences, 20 Dongdajie Street, Fengtai District, Beijing 100071, China. Hauptthemen laut MEDLINE: Thymosin, Transforming Growth Factor beta1, Pulmonary Fibrosis, Idiopathic Pulmonary Fibrosis. Die Arbeit nennt 32 Literaturangaben. Gefördert von: Shenzhen Science and Technology Program, The Fundamental Research Funds for the Central Universities, Nankai University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive, and fibrotic interstitial lung disease. The two drugs indicated for IPF have limited efficacy and there is an urgent need to develop new drugs. Thymosin β4 (Tβ4) is a natural endogenous repair factor whose antifibrotic effects have been reported. This study aimed to evaluate the effect of exogenous recombinant human thymosin beta 4 (rhTβ4) on pulmonary fibrosis.

Methods

Pulmonary fibrosis was induced in mice with bleomycin, and rhTβ4 was administrated by nebulization following three strategies: early dosing, mid-term dosing, and late dosing. The rhTβ4 efficacy was assessed by hydroxyproline, lung function, and lung histopathology. In vitro, the effects of rhTβ4 on fibroblast and lung epithelial cell phenotypes, as well as the TGF-β1 pathway, were evaluated. Key findings Aerosol administration of rhTβ4 could alleviate bleomycin-induced pulmonary fibrosis in mice at different stages of fibrosis. Studies conducted in vitro suggested that rhTβ4 could suppress lung fibroblasts from proliferating, migrating, and activation via regulating the TGF-β1 signalling pathway. In vitro, rhTβ4 also inhibited the epithelial-mesenchymal transition-like process of pulmonary epithelial cells.

Conclusions

This study suggests that nebulized rhTβ4 is a potential treatment for IPF.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ThymosinTransforming Growth Factor beta1Pulmonary FibrosisIdiopathic Pulmonary FibrosisAnimalsBleomycinSignal TransductionMiceAdministration, InhalationFibroblastsHumansMaleMice, Inbred C57BLRecombinant ProteinsLungDisease Models, AnimalEpithelial-Mesenchymal TransitionCell ProliferationEpithelial CellsThymosin beta(4)

Stichwörter der Autor:innen

TGF-β1idiopathic pulmonary fibrosisinhalationmyofibroblaststhymosin β4

Substanzen

BleomycinThymosinTransforming Growth Factor beta1Recombinant ProteinsThymosin beta(4)

Autor:innen und Institutionen

  • Institute of Biotechnology, Academy of Military Medical Sciences, 20 Dongdajie Street, Fengtai District, Beijing 100071, China.
  • State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy and Tianjin Key Laboratory of Molecular Drug Research, Nankai University, Haihe Education Park, 38 Tongyan Road, Tianjin 300353, China.

ORCID-Profile: Shimeng Li, Li Chen

Förderung

  • Shenzhen Science and Technology Program
  • The Fundamental Research Funds for the Central Universities
  • Nankai University
  • The National Natural Science Foundation of China

Zitieren

APA

Yu, R., Li, S., Chen, L., Hu, E., Chai, D., Liu, Z., Zhang, Q., Mao, Y., Zhai, Y., Li, K., Liu, Y., Li, X., Zhou, H., Yang, C., & Xu, J. (2025). Inhaled exogenous thymosin beta 4 suppresses bleomycin-induced pulmonary fibrosis in mice via TGF-β1 signalling pathway. Journal of Pharmacy and Pharmacology. https://doi.org/10.1093/jpp/rgae143

Vancouver

Yu R, Li S, Chen L, Hu E, Chai D, Liu Z, et al. Inhaled exogenous thymosin beta 4 suppresses bleomycin-induced pulmonary fibrosis in mice via TGF-β1 signalling pathway. Journal of Pharmacy and Pharmacology. 2025. doi:10.1093/jpp/rgae143

BibTeX
@article{Yu2025,
  author = {Yu, Rui and Li, Shimeng and Chen, Li and Hu, Enbo and Chai, Dan and Liu, Zhichao and Zhang, Qianyi and Mao, Yunyun and Zhai, Yanfang and Li, Kai and Liu, Yanhong and Li, Xiaohe and Zhou, Honggang and Yang, Cheng and Xu, Junjie},
  title = {Inhaled exogenous thymosin beta 4 suppresses bleomycin-induced pulmonary fibrosis in mice via TGF-β1 signalling pathway},
  journal = {Journal of Pharmacy and Pharmacology},
  year = {2025},
  doi = {10.1093/jpp/rgae143}
}
Kostenlos starten →